Zogenix CEO explains company pivot from opioids to epilepsy drugs

Steve Farr hopes he has Zogenix positioned for success in 2018 with ZX-008.

Source: bizjournals.com Health Care:Biotechnology headlines - January 4, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news